Construction of Neospora caninum stably expressing TgSAG1 and evaluation of its protective effects against Toxoplasma gondii infection in mice

Vaccine

Volumn 28, Issue 45, 2010, Pages 7243-7247

  Zhang, Guohong ^a   Huang, Xiaohong ^a,b   Boldbaatar, Damdinsuren ^a,c   Battur, Banzragch ^a,c   Battsetseg, Badgar ^a,c   Zhang, Houshuang ^a,c   Yu, Longzheng ^a   Li, Yan ^a   Luo, Yuzi ^a   Cao, Shinuo ^a   Goo, Youn Kyong ^a   Yamagishi, Junya ^a   Zhou, Jinlin ^a,d   Zhang, Shoufa ^a,e   Suzuki, Hiroshi ^a   Igarashi, Ikuo ^a   Mikami, Takeshi ^a   Nishikawa, Yoshifumi ^a   Xuan, Xuenan ^a  

^a OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^b FUJIAN NORMAL UNIVERSITY   (China)

^c MONGOLIAN UNIVERSITY OF LIFE SCIENCES   (Mongolia)

^d INSTITUTE OF PLANT PROTECTION   (China)

^e YANBIAN UNIVERSITY   (China)

Author keywords

Neospora caninum; Recombinant vaccine; TgSAG1; Toxoplasma gondii; Vector

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 4; MEMBRANE ANTIGEN; PARASITE ANTIGEN; PYRIMETHAMINE; RECOMBINANT VACCINE; TOXOPLASMA GONDII SURFACE ANTIGEN 1; TOXOPLASMA GONDII VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION; HUMORAL IMMUNITY; MOLECULAR WEIGHT; MOUSE; NEOSPORA CANINUM; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTECTION; TACHYZOITE; TOXOPLASMOSIS;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; FEMALE; IMMUNITY, HUMORAL; IMMUNODOMINANT EPITOPES; MICE; MICE, INBRED BALB C; NEOSPORA; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; RECOMBINANT PROTEINS; TH1 CELLS; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; TRANSFECTION;

EID: 77957753779     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.08.096     Document Type: Article

References (32)

1. Andrianarivo A.G., Barr B.C., Anderson M.L., Rowe J.D., Packham A.E., Sverlow K.W., et al. Immune responses in pregnant cattle and bovine fetuses following experimental infection with Neospora caninum. Parasitol Res 2001, 87(10):817-825.
2. Angus C.W., Klivington-Evans D., Dubey J.P., Kovacs J.A. Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents. J Infect Dis 2000, 181(1):317-324.
3. Beverley J.K.A. Congenital transmission of toxoplasmosis through successive generations of mice. Nature 1959, 183(4671):1348-1349.
4. Caetano B.C., Bruna-Romero O., Fux B., Mendes E.A., Penido M.L., Gazzinelli R.T. Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of Toxoplasma gondii induces immune response and protection against infection in mice. Hum Gene Ther 2006, 17(4):415-426.
5. + T cell-dependent protective immunity against malaria. J Immunol 2000, 165(4):2084-2092.
6. Cong H., Gu Q.M., Jiang Y., He S.Y., Zhou H.Y., Yang T.T., et al. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii. Parasite Immunol 2005, 27(1-2):29-35.
7. De Marez T., Liddell S., Dubey J.P., Jenkins M.C., Gasbarre L. Oral infection of calves with Neospora caninum oocysts from dogs: humoral and cellular immune responses. Int J Parasitol 1999, 29(10):1647-1657.
8. Di Cristina M., Ghouze F., Kocken C.H.M., Naitza S., Cellini P., Soldati D., et al. Transformed Toxoplasma gondii tachyzoites expressing the circumsporozoite protein of Plasmodium knowlesi elicit a specific immune response in rhesus monkeys. Infect Immun 1999, 67(4):1677-1682.
9. Dubey J.P., Carpenter J.L., Speer A., Topper M.J., Uggla A. Newly recognized fatal protozoan disease of dogs. J Am Vet Med Assoc 1988, 192(9):1269-1285.
10. Ellis J., Luton K., Baverstock P.R., Brindley P.J., Nimmo K.A., Johnson A.M. The phylogeny of Neospora caninum. Mol Biochem Parasitol 1994, 64(2):303-311.
11. Haumont M., Delhaye L., Garcia L., Jurado M., Mazzu P., Daminet V., et al. Protective immunity against congenital toxoplasmosis with recombinant SAG1 protein in a guinea pig model. Infect Immun 2000, 68(9):4948-4953.
12. Hill D., Dubey J.P. Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microbiol Infect 2002, 8(10):634-640.
13. Howe D.K., Mercier C., Messina M., Sibley L.D. Expression of Toxoplasma gondii genes in the closely related apicomplexan parasite Neospora caninum. Mol Biochem Parasitol 1997, 86(1):29-36.
14. Kasper L.H., Khan I.A. Antigen-specific CD8+ T cells protect against lethal toxoplasmosis in mice infected with Neospora caninum. Infect. Immun. 1998, 66(4):1554-1560.
15. Khan I.A., Schwartzman J.D., Fonseka S., Kasper L.H. Neospora caninum: role for immune cytokines in host immunity. Exp Parasitol 1997, 85(1):24-34.
16. Kimbita E.N., Xuan X., Huang X., Miyazawa T., Fukumoto S., Mishima M., et al. Serodiagnosis of Toxoplasma gondii infection in cats by enzyme-linked immunosorbent assay using recombinant SAG1. Vet Parasitol 2001, 102(1-2):35-44.
17. Kur J., Holec-Gasior L., Hiszczynska-Sawicka E. Current status of toxoplasmosis vaccine development. Expert Rev Vaccines 2009, 8(6):791-808.
18. Luft B.J., Brooks R.J., Conley F.K., McCabe R.E., Remington J.S. Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome. J Am Med Assoc 1984, 252(7):913-917.
19. Lunden A., Marks J., Maley S.W., Innes E.A. Cellular immune response in cattle experimentally infected with Neospora caninum. Parasite Immunol 1998, 20(11):519-526.
20. Mishima M., Xuan X., Nishikawa Y., Makala L., Yokoyama N., Nagasawa H., et al. Construction of recombinant feline herpesvirus type 1 expressing Toxoplasma gondii surface antigen 1. Mol Biochem Parasitol 2001, 117(1):103-106.
21. Nielsen H.V., Lauemoller S.L., Christiansen L., Buus S., Fomsgaard A., Petersen E. Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene. Infect Immun 1999, 67(12):6358-6363.
22. Nishikawa Y., Xuan X., Nagasawa H., Igarashi I., Fujisaki K., Otsuka H., et al. Monoclonal antibody inhibition of Neospora caninum tachyzoite invasion into host cells. Int J Parasitol 2000, 30(1):51-58.
23. Nishikawa Y., Xuan X., Makala L., Vielemeyer O., Joiner K.A., Nagasawa H. Characterization of Toxoplasma gondii engineered to express mouse interferon-gamma. Int J Parasitol 2003, 33(13):1525-1535.
24. Petersen E., Nielsen H.V., Christiansen L., Spenter J. Immunization with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii. Vaccine 1998, 16(13):1283-1289.
25. Roberts A., Hedman K., Luyasu V., Zufferey J., Bessières M.H., Blatz R.M., et al. Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii. Eur J Clin Microbiol Infect Dis 2001, 20(7):467-474.
26. Sabin A.B. Toxoplasmic encephalitis in children. J Am Med Assoc 1941, 116:801-807.
27. Seeber F., Dubremetz J.F., Boothroyd J.C. Analysis of Toxoplasma gondii stably transfected with a transmembrane variant of its major surface protein, SAG1. J Cell Sci 1998, 111(1):23-29.
28. Sibley L.D., Messina M., Niesman I.R. Stable DNA transformation in the obligate intracellular parasite Toxoplasma gondii by complementation of tryptophan auxotrophy. Proc Natl Acad Sci USA 1994, 91(12):5508-5512.
29. Shirafuji H., Xuan X., Kimata I., Takashima Y., Shinya F., Otsuka H., et al. Expression of P23 of Cryptosporidium parvum in Toxoplasma gondii and evaluation of its protective effects. J Parasitol 2005, 91(2):476-479.
30. Stover C.K. Recombinant vaccine delivery systems and encoded vaccines. Curr Opin Immunol 1994, 6(4):568-571.
31. Tenter A.M., Heckeroth A.R., Weiss L.M. Toxoplasma gondii: from animals to humans. Int J Parasitol 2000, 30(12-13):1217-1258.
32. Yap G.S., Sher A. Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function. Immunobiology 1999, 201(2):240-247.